Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-05-24 @ 1:02 PM
Study NCT ID:
NCT03463460
Status:
RECRUITING
Last Update Posted:
2025-08-24
First Post:
2018-02-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
Sponsor:
Organization: